Telehealth Anxiety Prescribing: What Prescribers Can Do in Pennsylvania

If you’re a psychiatrist or PMHNP wondering whether you can prescribe anxiety medications through telehealth — including controlled substances like benzodiazepines — the short answer is yes. But the full answer depends on your state, your credentials, and understanding the regulatory landscape that’s still evolving in 2026.

Here’s what you actually need to know to practice telehealth psychiatry for anxiety treatment without running into compliance issues or leaving money on the table.

The Federal Telehealth Flexibility You’re Still Operating Under

The biggest question providers ask: Can I prescribe benzos or other controlled anxiety meds without seeing the patient in person first?

Yes — through at least December 2026.

The DEA and HHS extended the COVID-era telemedicine flexibilities that waive the Ryan Haight Act’s in-person requirement for controlled substance prescribing. This means you can initiate and manage medications like alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and even Schedule II stimulants for comorbid ADHD — all via video visit, with no initial face-to-face exam required.

In 2024 alone, over 7 million controlled substance prescriptions for conditions like anxiety and ADHD were written via telehealth under these rules. The extension through 2026 gives regulators time to craft permanent telemedicine prescribing rules, which will likely include a special DEA telemedicine registration rather than requiring in-person visits.

What this means for you: You can build or join a purely virtual practice managing anxiety patients right now. Just stay alert to DEA announcements in late 2026 about the permanent framework — but for the next year, you’re operating under clear federal authority to prescribe remotely.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State Telehealth Rules: Where the Real Variation Lives

Federal flexibility is one thing. State prescribing laws are another.

Most states align with federal policy for telehealth prescribing, but a few impose additional conditions that matter for anxiety treatment:

Florida

Florida generally bans telemedicine prescribing of Schedule II controlled substances — except for psychiatric disorders. So if you’re treating anxiety (or co-occurring ADHD with a stimulant), you’re explicitly permitted to prescribe via telehealth.

Benzodiazepines are Schedule IV, so they’re not subject to Florida’s Schedule II telehealth restriction at all. The catch: if you’re an out-of-state provider using Florida’s telehealth registration (not a full FL license), you cannot prescribe controlled substances remotely. You need full Florida licensure and a DEA registration for that.

Florida also mandates checking the state PDMP (E-FORCSE) before prescribing any controlled medication — every time, no exceptions.

Texas

Texas allows telehealth prescribing of controlled substances for psychiatric conditions, but explicitly prohibits using telemedicine to treat chronic pain with scheduled drugs. Anxiety treatment doesn’t fall under ‘chronic pain,’ so you’re clear to prescribe benzodiazepines or other anxiolytics remotely.

Texas requires a valid patient-practitioner relationship established via live audio-visual exam, and you must check the Texas PDMP (PMP Aware) before prescribing controlled meds. There are no telehealth-specific quantity limits for physicians — just standard medical practice guidelines.

Texas participates in the Interstate Medical Licensure Compact (IMLC), which can streamline getting licensed in multiple states if you want to expand your telehealth reach.

California

No special state restrictions beyond federal law. You can conduct a psychiatric evaluation via video, prescribe SSRIs, SNRIs, or benzodiazepines, and manage follow-ups entirely online — as long as you have a California DEA registration.

California’s telehealth payment parity law (AB 744) ensures private insurers pay the same rate for virtual visits as in-person, which removes the financial penalty for practicing remotely.

California does not participate in the IMLC, so you’ll need a full CA medical license to treat California patients by telehealth (no shortcuts).

New York

New York integrates telehealth into standard practice with no separate prescribing restrictions. You can prescribe controlled anxiety medications via telemedicine just as you would in person.

The key compliance requirement: New York has one of the strictest PDMP mandates in the country. You must check the iSTOP database for every controlled substance prescription — including benzodiazepines — with very few exceptions.

One consideration for Medicare patients: federal rules previously required an in-person visit within 6 months to continue tele-mental health services. Congress has delayed enforcement through 2024–2025, but verify current Medicare policy if you’re treating Medicare patients for anxiety remotely.

Pennsylvania & Illinois

Neither state has telehealth-specific prescribing prohibitions for mental health. You can manage anxiety medications via telemedicine under the same standards of care as in-person practice.

Both states mandate PDMP checks for controlled substances. Illinois implemented telehealth parity in 2021, requiring insurers to cover tele-mental health equivalently — which likely improves your reimbursement. Pennsylvania doesn’t have comprehensive telehealth legislation, but most insurers voluntarily pay parity for telepsychiatry.

Bottom line: As a psychiatrist, you have wide latitude to use your full prescriptive authority via telehealth. Stay compliant with PDMP requirements, document your patient evaluations properly, and track the DEA’s upcoming permanent rules.

PMHNP vs MD: The Authority Gap That Still Exists in Many States

If you’re a Psychiatric Mental Health Nurse Practitioner, your telehealth prescribing authority for anxiety depends heavily on your state’s scope of practice laws.

Full Practice Authority States (FPA)

In states like New York, Oregon, Washington, Arizona, PMHNPs can evaluate, diagnose, and prescribe anxiety medications — including controlled substances — without any physician supervision. Your authority is essentially equivalent to a psychiatrist’s.

New York is particularly notable: as of 2022, the state enacted full practice authority, removing the prior 3,600-hour collaborative agreement requirement. Any NY-licensed PMHNP can now manage anxiety meds independently, which dramatically expands the pool of autonomous anxiety prescribers.

Reduced/Restricted Practice States

States like California, Texas, Florida, Pennsylvania require PMHNPs to maintain a formal relationship with a physician to prescribe.

California is mid-transition: AB 890 created a pathway for experienced NPs to practice independently. As of January 2023, qualified NPs can become ‘103 NPs’ and practice without standardized physician procedures in group settings. Starting January 2026, those with 3 years of experience can become ‘104 NPs’ with full independent practice authority — including solo telehealth work.

Until you achieve 104 status, you operate under physician agreements. The good news: California NPs already could prescribe controlled substances with a furnishing number and physician protocol; AB 890 mainly removes the protocol requirement for qualified providers.

Texas remains restrictive: PMHNPs must have a Prescriptive Authority Agreement with a physician to prescribe anything. Additionally, Texas limits NP prescribing of Schedule II controlled substances to hospital-based settings, hospice, or terminally ill patients. For anxiety treatment, this means you cannot prescribe stimulants in outpatient settings (though benzodiazepines are Schedule IV and permitted with physician delegation).

Florida requires PMHNPs to practice under a written protocol with a physician. The state created limited NP independence for primary care in 2020, but explicitly excluded psychiatry. However, Florida psychiatric NPs prescribing mental health medications are exempt from the usual 7-day limit on controlled substance prescriptions — you can prescribe more than 7 days of benzodiazepines if you’re treating an anxiety disorder.

Pennsylvania requires a Collaborative Agreement with a physician for the entire career of the NP — there’s no pathway to independence unless laws change. The physician must review charts and countersign Schedule II prescriptions within specific timeframes.

Illinois offers a transition path: after 4,000 clinical hours and 250 hours of continuing education, PMHNPs can apply for Full Practice Authority. Even with FPA, Illinois NPs need a one-time physician attestation to prescribe benzodiazepines or Schedule II narcotics — essentially a sign-off acknowledging you’ll prescribe those classes.

What This Means for Your Practice

If you’re a PMHNP in a restricted state, you’ll need to find a psychiatrist or physician willing to collaborate (which may involve fees). Geographic restrictions may apply — Texas requires the physician and NP to be within 75 miles in most cases.

For telehealth, this can limit your ability to operate purely remotely without a local physician partner. This is where platforms like Klarity Health add value: they can help pair you with collaborating physicians or focus recruiting in states where you can practice with minimal oversight.

What Anxiety Medication Management Actually Pays in 2026

Understanding reimbursement is critical — especially if you’re considering joining a telehealth platform or evaluating whether the economics work for virtual practice.

Medicare Rates

Medicare pays surprisingly well for psychiatric medication management:

• 90792 (initial psychiatric evaluation with medication): ~$202
• 99213 (15-minute follow-up med check): ~$95
• 99214 (25-minute moderate-complexity visit): ~$136
• 90833 (30-minute therapy add-on): ~$81

Medicare’s telehealth parity extension through 2026 means you’re paid the same rate for virtual visits as in-person. There’s no financial penalty for practicing remotely.

Medicaid Rates

Medicaid varies by state but generally pays 50–60% of Medicare rates:

• 90792: ~$85
• 99213: ~$43

The lower rates are offset by high patient volume. Many states increased Medicaid behavioral health rates recognizing provider shortages. Most states now permanently allow psychiatric medication management via telehealth and reimburse it equally to in-person care.

Commercial Insurance

Private insurers typically pay 100–150% of Medicare rates, averaging $100–$120 for a standard medication management visit (99213). Telehealth parity laws in states like California (AB 744), Illinois, and New York require insurers to pay the same rate for virtual visits as in-person when the service is equivalent.

PMHNP Reimbursement

If you’re an NP billing under your own NPI, Medicare reimburses at 85% of the physician fee schedule. For example, if a psychiatrist gets $100 for a visit, you’d get $85.

Some private insurers credential NPs and pay at similar reduced rates. Medicaid in some states pays NPs the same as MDs; others pay ~90%. This reimbursement difference is something to factor when negotiating with employers or platforms.

‘Incident to’ billing (where an NP’s service is billed under a physician’s NPI at 100% rate) generally isn’t feasible in telehealth psychiatry.

The Platform Advantage

Many telehealth providers aim to optimize volume and efficiency to make up for moderate per-session fees. The overhead is dramatically lower in telehealth (no office rent, reduced staffing), and platforms often handle all billing and credentialing.

For context: instead of spending $3,000–5,000/month on marketing with uncertain results (SEO takes 6–12 months to generate meaningful patient flow, Google Ads for mental health keywords cost $15–40+ per click with a realistic cost per booked patient of $200–400+), platforms like Klarity use a pay-per-appointment model where you only pay when a qualified patient books with you.

That’s guaranteed ROI versus gambling on marketing channels you may not have the budget, expertise, or patience to optimize.

The Patient Acquisition Reality No One Talks About

Let’s address the elephant in the room: how do you actually get anxiety patients if you’re starting a telehealth practice or joining a platform?

DIY marketing is expensive and slow. Acquiring a qualified psychiatric patient through SEO, Google Ads, or directories typically costs $200–500+ when you factor in:

• Agency/consultant fees
• Ad spend testing and optimization
• Staff time to handle and qualify leads
• No-show rates from cold leads
• Months of SEO investment before results
• Failed campaigns

SEO takes 6–12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience for this.

Google Ads for mental health keywords are expensive ($15–40+ per click) and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200–400+.

Directory listings like Psychology Today or Zocdoc charge monthly fees AND you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35–100+), but total monthly cost including subscription adds up quickly.

The Klarity Health Model

Klarity uses a pay-per-appointment model similar to Zocdoc’s approach, but with key differences:

• No upfront marketing spend or monthly subscription fees — you’re not gambling thousands of dollars hoping for results
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert to actual appointments
• Built-in telehealth infrastructure — no separate platform costs
• Both insurance and cash-pay patient flow to diversify your revenue
• You control your schedule — only pay when you actually see patients

Instead of spending thousands monthly on marketing with uncertain outcomes, you pay a standard listing fee per new patient lead. That’s the business case: guaranteed patient acquisition cost versus unpredictable marketing ROI.

DIY marketing can eventually be cost-effective IF you have the budget, expertise, and patience. But for most providers — especially those starting out or scaling — a platform that handles patient acquisition removes the risk entirely.

The Workforce Shortage Creating Your Opportunity

Anxiety disorders are among the most common mental health conditions in the U.S., and demand for medication management is high nationwide — particularly in states facing significant provider shortages.

Texas: One psychiatrist serves about 8,966 residents on average (well above the national ratio of ~1:5,000). The state’s population growth and limited psychiatric training programs create persistent gaps in care.

Florida: Similar ratio at 1:8,577, with demand concentrated in growing metropolitan areas and retirement communities where anxiety and depression are prevalent.

Illinois: Ratio of 1:5,849, with severe shortages downstate outside Chicago.

These shortages, combined with rising anxiety cases post-pandemic, mean telehealth platforms can help you reach underserved areas profitably. Many providers search for opportunities to practice across state lines via licensure compacts or telehealth registrations to meet these needs.

Joining a telepsychiatry platform gives anxiety specialists:

• Access to broader patient populations across multiple states
• Streamlined credentialing and reimbursement handling
• Flexible practice within state regulatory bounds
• Protected time for clinical work instead of marketing and admin

Making the Move: What to Consider

If you’re evaluating whether telehealth anxiety prescribing fits your practice:

For Psychiatrists:

• You have full authority in all states — your main consideration is licensure and understanding each state’s PDMP requirements
• Multi-state practice via IMLC (if available in your states) can expand your patient pool efficiently
• Reimbursement is solid and telehealth parity protects your income
• The federal extension through 2026 gives you clear authority to prescribe controlled substances remotely

For PMHNPs:

• Know your state’s scope of practice and whether you need a collaborating physician
• If you’re in a restricted state, platforms that provide physician collaboration remove a major barrier
• States with FPA (or pathways to FPA) give you the most autonomy and income potential
• The 85% Medicare reimbursement rate is offset by lower overhead and higher patient volume in telehealth settings

For Both:

• Patient acquisition is the hardest part of building a practice — platforms that deliver qualified patients remove that risk
• Telehealth eliminates geographic constraints and office overhead
• Understanding your economics (reimbursement rates, patient volume, acquisition costs) is critical to building sustainable income
• The regulatory landscape is stabilizing in a provider-friendly direction, but staying informed on DEA rules and state law changes is non-negotiable

FAQ

Can psychiatrists prescribe benzodiazepines via telehealth without seeing the patient in person first?

Yes, through at least December 2026. The DEA and HHS extended COVID-era telemedicine flexibilities that waive the in-person requirement for controlled substance prescribing. You can initiate and manage benzodiazepines like Xanax, Klonopin, or Ativan entirely via video visit.

Do state laws restrict telehealth prescribing of anxiety medications?

Most states align with federal policy, but a few have specific rules. Florida permits telemedicine prescribing of Schedule II psychiatric medications. Texas prohibits controlled substance prescribing via telehealth for chronic pain (but not anxiety). California, New York, Pennsylvania, and Illinois have no special telehealth prescribing restrictions beyond federal requirements and PDMP checks.

Can PMHNPs prescribe anxiety medications independently?

It depends on your state. In Full Practice Authority states like New York (as of 2022), Oregon, Washington, and Arizona, PMHNPs can prescribe anxiety medications including controlled substances without physician supervision. In restricted states like Texas, Florida, and Pennsylvania, you need a collaborative agreement with a physician. California is transitioning to independence for experienced NPs as of 2026.

What’s the difference between PMHNP and psychiatrist prescribing authority for controlled substances?

Psychiatrists (MD/DO) can prescribe any controlled substance independently in all states. PMHNPs face varying regulations — from full independence in FPA states to mandatory physician supervision in restricted states. Some states (like Texas) specifically limit NP prescribing of Schedule II stimulants to hospital settings, though benzodiazepines (Schedule IV) are generally permitted with proper delegation.

How much does Medicare pay for anxiety medication management visits?

Medicare pays approximately $202 for an initial psychiatric evaluation (90792), $95 for a 15-minute follow-up (99213), and $136 for a 25-minute visit (99214) as of 2026. Telehealth visits are reimbursed at the same rate as in-person through at least 2026.

Does insurance pay the same rate for telehealth as in-person psychiatric care?

In most cases, yes. Medicare’s telehealth parity extension runs through 2026. Many states have permanent parity laws requiring private insurers to pay equal rates for telehealth mental health services — including California (AB 744), Illinois, and New York. Medicaid in most states also covers tele-mental health at parity.

What are the PDMP requirements for prescribing anxiety medications?

Nearly all states require checking the Prescription Drug Monitoring Program before prescribing controlled substances. New York has one of the strictest mandates — you must check iSTOP for every controlled medication prescription. Florida requires E-FORCSE checks, Texas requires PMP Aware, and most other states have similar databases with varying check frequencies (typically before initial prescription and periodically thereafter).

Can out-of-state providers prescribe anxiety medications via telehealth in Florida?

Only if you have a full Florida medical license and DEA registration. Florida offers an out-of-state telehealth provider registration, but those registrants cannot prescribe controlled substances remotely. To prescribe benzodiazepines or other anxiety medications to Florida patients, you need full licensure.

What’s the realistic cost to acquire a patient through DIY marketing versus a telehealth platform?

DIY marketing (SEO, Google Ads, directories) typically costs $200–500+ per acquired patient when factoring in agency fees, ad spend, staff time, no-shows, and failed campaigns. SEO takes 6–12 months before generating meaningful results. Platforms like Klarity use a pay-per-appointment model — you pay a standard listing fee only when a qualified patient books, eliminating upfront marketing risk and guaranteeing ROI.

Will the DEA telemedicine flexibilities become permanent?

The current extension runs through December 2026. The DEA is crafting permanent regulations expected to include a special telemedicine prescribing registration rather than requiring in-person visits. The extension gives regulators time to create rules that balance patient access with safety. Providers should monitor DEA announcements in late 2026 for the final framework.

Join Klarity Health’s Provider Network

If you’re ready to practice telehealth psychiatry for anxiety treatment without the marketing headaches, administrative burden, or regulatory uncertainty, Klarity Health offers a straightforward path.

What you get:

• Pre-qualified anxiety patients matched to your specialty and schedule
• Pay-per-appointment model — no upfront marketing costs or monthly fees
• Full telehealth infrastructure included
• Support with multi-state licensing and physician collaboration (for PMHNPs in restricted states)
• Insurance and cash-pay patient flow
• Complete control over your schedule and patient load

Who we’re looking for:

• Psychiatrists (MD/DO) licensed in priority states
• PMHNPs with prescribing authority (independent or collaborative)
• Providers interested in flexible, sustainable telehealth practice
• Clinicians who want to focus on patient care, not patient acquisition

Explore joining Klarity’s provider network and start seeing anxiety patients on your terms — without gambling thousands on marketing that may never pay off.

Citations

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html) — Official federal announcement confirming extension of controlled substance telemedicine prescribing through December 2026.

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (https://www.flsenate.gov/laws/statutes/2024/464.012 and https://www.flsenate.gov/laws/statutes/2022/456.47) — State law defining PMHNP scope, controlled substance limits, and telehealth prescribing exemptions for psychiatric treatment.

3. California Board of Registered Nursing – AB 890 Implementation (https://rn.ca.gov/practice/ab890.shtml) — Official guidance on California’s transition to NP independent practice (103 NP and 104 NP categories effective 2023–2026).

4. New York State Nurse Practitioner Association – ‘NP Modernization Act Passes’ (https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes) — Announcement of New York’s 2022 law granting full practice authority to PMHNPs.

5. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (https://therathink.com/insurance-reimbursement-rates-for-psychiatrists/) — Analysis of Medicare, Medicaid, and private insurance reimbursement rates for psychiatric medication management using CMS data.

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs